https://www.thebostonexaminer.com/article/906400436-lab-movers-outlines-best-practices-for-transporting-high-value-sensitive-lab-equipment The Boston Examiner en PressRelease 2026-04-18T01:08:09+00:00 Lab Movers Outlines Best Practices for Transporting High-Value Sensitive Lab Equipment https://www.thebostonexaminer.com/article/906143494-angiex-reports-aacr-in-vivo-data-supporting-agx101-in-combination-with-immune-checkpoint-inhibitors-for-solid-tumors The Boston Examiner en PressRelease 2026-04-17T19:00:00+00:00 Angiex Reports AACR In Vivo Data Supporting AGX101 in Combination With Immune Checkpoint Inhibitors for Solid Tumors https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834553-angiex-logo-925x925.jpeg https://www.thebostonexaminer.com/article/906341038-stark-moving-and-storage-takes-home-2026-boston-business-excellence-award The Boston Examiner en PressRelease 2026-04-17T18:18:11+00:00 Stark Moving and Storage Takes Home 2026 Boston Business Excellence Award https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24160398-stark-movers-and-storage-220x78.png https://www.thebostonexaminer.com/article/906316810-bob-grant-president-of-grant-marketing-earns-scaling-ai-professional-certificate The Boston Examiner en PressRelease 2026-04-17T17:28:29+00:00 Bob Grant, President of Grant Marketing, Earns Scaling AI Professional Certificate https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835353-bob-grant-president-540x300.jpeg https://www.thebostonexaminer.com/article/906324149-bodkin-design-s-new-website-offers-free-exclusive-tools-for-vision-system-designers The Boston Examiner en PressRelease 2026-04-17T17:17:05+00:00 Bodkin Design’s New Website Offers Free Exclusive Tools for Vision System Designers https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835298-ir-calibration-image-640x480.jpeg https://www.thebostonexaminer.com/article/906302743-varstreet-gives-end-customers-real-time-stock-visibility-directly-on-the-ecommerce-store The Boston Examiner en PressRelease 2026-04-17T13:53:08+00:00 VARStreet Gives End-Customers Real-Time Stock Visibility Directly on the eCommerce Store https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/743488-varstreet-logo-2000x2000.jpeg https://www.thebostonexaminer.com/article/906194208-new-england-to-host-first-ever-amputee-soccer-open-cup-in-world-cup-year The Boston Examiner en PressRelease 2026-04-17T13:00:00+00:00 New England to host first ever Amputee Soccer Open Cup in World Cup year https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834808-neasa-open-cup-2-371x354.png https://www.thebostonexaminer.com/article/906376026-zenas-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-17T20:15:00+00:00 Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg https://www.thebostonexaminer.com/article/906375662-camp4-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-17T20:05:00+00:00 CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba/small/cmp4-21-logo-full-color-jpg.jpg https://www.thebostonexaminer.com/article/906376697-pyxis-oncology-to-present-new-preclinical-data-showing-synergistic-anti-tumor-activity-in-a-hnscc-model-with-mamicvo-in-combination-with-anti-pd-1-at The Boston Examiner en PressRelease 2026-04-17T20:05:00+00:00 Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026 https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg https://www.thebostonexaminer.com/article/906375816-xilio-therapeutics-announces-new-preclinical-data-at-aacr-annual-meeting-for-xtx601-a-masked-t-cell-engager-targeting-cldn18-2 The Boston Examiner en PressRelease 2026-04-17T20:01:00+00:00 Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2 https://ml.globenewswire.com/media/7e55cc25-f46f-423c-bf2a-e77ebaf69665/small/xilio-full-clr-logo-cmyk-png.png https://www.thebostonexaminer.com/article/906376317-hingham-savings-reports-first-quarter-2026-results The Boston Examiner en PressRelease 2026-04-17T20:01:00+00:00 Hingham Savings Reports First Quarter 2026 Results https://ml.globenewswire.com/media/d0d093ef-e484-4e52-808f-05772a91d549/small/hingham-institution-for-savings-logo.jpg https://www.thebostonexaminer.com/article/906376533-acrivon-to-highlight-preclinical-data-with-three-posters-at-aacr-demonstrating-strong-acr-368-and-acr-2316-synergies-with-immune-checkpoint-inhibitors The Boston Examiner en PressRelease 2026-04-17T20:00:00+00:00 Acrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and ADC Payloads, Revealing Broad Clinical Development Opportunities https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg https://www.thebostonexaminer.com/article/906351124-crestwood-advisors-named-once-again-to-usa-today-s-2026-best-financial-advisory-firms-list The Boston Examiner en PressRelease 2026-04-17T19:00:00+00:00 Crestwood Advisors Named Once Again to USA TODAY’s 2026 Best Financial Advisory Firms List https://ml.globenewswire.com/media/NzM2NTUxNTEtODEyMS00ZjhmLWJhMGEtNDY5ZTBiMTQ2NmRkLTUwMDE1NDUyOS0yMDI2LTA0LTE3LWVu/tiny/Crestwood-Advisors.png https://www.thebostonexaminer.com/article/906351224-pacemakers-market-to-reach-7-5-billion-by-2030-driven-by-expanding-clinical-indications-and-aging-demographics The Boston Examiner en PressRelease 2026-04-17T17:08:16+00:00 Pacemakers Market to Reach $7.5 Billion by 2030, Driven by Expanding Clinical Indications and Aging Demographics https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.thebostonexaminer.com/article/906209152-movers-near-me-searches-could-mislead-brookline-residents-stark-moving-and-storage-advises The Boston Examiner en PressRelease 2026-04-17T02:28:15+00:00 Movers Near Me’ Searches Could Mislead Brookline Residents, Stark Moving and Storage Advises https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24160398-stark-movers-and-storage-220x78.png https://www.thebostonexaminer.com/article/906310206-connectm-delivers-93-gross-profit-growth-in-transformational-fiscal-year-2025-targets-75-million-revenue-and-positive-ebitda-for-fiscal-year-2026 The Boston Examiner en PressRelease 2026-04-17T13:00:00+00:00 ConnectM Delivers 93% Gross Profit Growth in Transformational Fiscal Year 2025; Targets $75 Million Revenue and Positive EBITDA for Fiscal Year 2026 https://ml.globenewswire.com/media/3c055590-9c6e-4665-8817-37d7bc3adca8/small/cntm-logo-300ppi-png.png https://www.thebostonexaminer.com/article/906308984-first-steps-developmental-services-expands-services-in-woburn The Boston Examiner en PressRelease 2026-04-17T12:05:00+00:00 First Steps Developmental Services Expands Services in Woburn https://ml.globenewswire.com/media/ZjcwZDJhNDEtZjQ3Yi00MTFiLTg0MjYtOGUyZWRkZmE5NmY4LTEzMjI2NDctMjAyNi0wNC0xNy1lbg==/tiny/First-Steps-Developmental-Serv.png https://www.thebostonexaminer.com/article/906309333-cogent-biosciences-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2026 The Boston Examiner en PressRelease 2026-04-17T12:00:00+00:00 Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026 https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png https://www.thebostonexaminer.com/article/906310108-lyra-therapeutics-inc-announces-intention-to-voluntarily-file-form-25-for-delisting-from-nasdaq-and-subsequent-deregistration-with-the-sec The Boston Examiner en PressRelease 2026-04-17T12:00:00+00:00 Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC https://ml.globenewswire.com/media/0ad06b18-5b96-4274-8aa8-c57f0a1a8a87/small/lyra-logo-rgb-small-jpg.jpg https://www.thebostonexaminer.com/article/906310710-repligen-opens-european-training-innovation-center-in-breda-expanding-global-customer-support-network The Boston Examiner en PressRelease 2026-04-17T11:30:00+00:00 Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network https://ml.globenewswire.com/media/967d43f6-7ffd-4ee0-8804-e3c12952402f/small/repligen-logo-horizontal-withtagline-1-jpg.jpg https://www.thebostonexaminer.com/article/906283356-upstream-bio-to-present-new-data-from-phase-2-vibrant-trial-of-verekitug-at-the-ats-2026-international-conference The Boston Examiner en PressRelease 2026-04-17T11:00:00+00:00 Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference https://ml.globenewswire.com/media/f1393297-d0b6-4706-960f-6128bcd0c6a4/small/upstream-logo-rgb-300x300px-jpg.jpg https://www.thebostonexaminer.com/article/906282455-mediamelon-joins-akamai-qualified-compute-partner-program-to-deliver-real-time-streaming-analytics-at-global-scale The Boston Examiner en PressRelease 2026-04-17T10:30:00+00:00 MediaMelon Joins Akamai Qualified Compute Partner Program to Deliver Real-Time Streaming Analytics at Global Scale https://ml.globenewswire.com/media/4ce7685a-3da0-416d-9bc1-58cc8b7812b8/small/akamai-logo-color-rgb-bluenavy-png.png https://www.thebostonexaminer.com/article/906157437-dr-gail-christopher-reflects-on-five-decades-of-advocacy-for-black-maternal-health-at-black-maternal-health-conference The Boston Examiner en PressRelease 2026-04-16T20:02:06+00:00 Dr. Gail Christopher Reflects on Five Decades of Advocacy for Black Maternal Health at Black Maternal Health Conference https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/20982111-nche-new-logo-2068x831.png https://www.thebostonexaminer.com/article/906198900-kailera-therapeutics-announces-pricing-of-initial-public-offering The Boston Examiner en PressRelease 2026-04-16T23:25:37+00:00 Kailera Therapeutics Announces Pricing of Initial Public Offering https://ml.globenewswire.com/media/c0b33a3d-0c2b-45b0-ace8-6ff585b41339/small/kailera-logo-png.png https://www.thebostonexaminer.com/article/906181568-carnegie-research-students-more-concerned-with-higher-ed-s-feasibility The Boston Examiner en PressRelease 2026-04-16T20:26:15+00:00 Carnegie research: Students more concerned with higher ed’s feasibility https://ml.globenewswire.com/media/N2M0ZGRhMzMtZmJmNi00MDEwLWJhMjUtYjk4MmQzNWIwY2ZhLTUwMDE1NzQ4OS0yMDI2LTA0LTE2LWVu/tiny/Carnegie.png https://www.thebostonexaminer.com/article/906181421-spyre-therapeutics-inc-announces-closing-of-public-offering-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares-for-gross The Boston Examiner en PressRelease 2026-04-16T20:15:00+00:00 Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.thebostonexaminer.com/article/906180879-eyepoint-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-16T20:01:00+00:00 EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/3934240c-3155-4c7d-a525-885791fdab8b/small/eypoint-new-reg-vertical-3c-rgb1-jpg.jpg